FRESENIUS Financial Statements From 2010 to 2024
| FREA Stock | EUR 8.10 0.05 0.61% |
Check FRESENIUS SECO financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among FRESENIUS SECO's main balance sheet or income statement drivers, such as , as well as many indicators such as . FRESENIUS financial statements analysis is a perfect complement when working with FRESENIUS SECO Valuation or Volatility modules.
FRESENIUS |
FRESENIUS SECO ADR Company Profit Margin Analysis
FRESENIUS SECO's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current FRESENIUS SECO Profit Margin | 0.04 % |
Most of FRESENIUS SECO's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, FRESENIUS SECO ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, FRESENIUS SECO ADR has a Profit Margin of 0.0402%. This is 100.36% lower than that of the Healthcare sector and 100.79% lower than that of the Medical Care industry. The profit margin for all Germany stocks is 103.17% lower than that of the firm.
FRESENIUS SECO ADR Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining FRESENIUS SECO's current stock value. Our valuation model uses many indicators to compare FRESENIUS SECO value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across FRESENIUS SECO competition to find correlations between indicators driving FRESENIUS SECO's intrinsic value. More Info.FRESENIUS SECO ADR is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about 0.37 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for FRESENIUS SECO ADR is roughly 2.72 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the FRESENIUS SECO's earnings, one of the primary drivers of an investment's value.About FRESENIUS SECO Financial Statements
FRESENIUS SECO stakeholders use historical fundamental indicators, such as FRESENIUS SECO's revenue or net income, to determine how well the company is positioned to perform in the future. Although FRESENIUS SECO investors may analyze each financial statement separately, they are all interrelated. For example, changes in FRESENIUS SECO's assets and liabilities are reflected in the revenues and expenses on FRESENIUS SECO's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in FRESENIUS SECO ADR. Please read more on our technical analysis and fundamental analysis pages.
KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Hhe, Germany. FRESENIUS SECO operates under Medical Care classification in Germany and is traded on Frankfurt Stock Exchange. It employs 288459 people.
Currently Active Assets on Macroaxis
Other Information on Investing in FRESENIUS Stock
FRESENIUS SECO financial ratios help investors to determine whether FRESENIUS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in FRESENIUS with respect to the benefits of owning FRESENIUS SECO security.